ACPA status, as measured using the commercial CCP2 assay previously described, was available in 168 RA patients (37 BRAGGSS, 131 RAMS), and 90 of these 168 patients were ACPA positive (53.6%). Here, AGBL2 is linked to rheumatoid arthritis.